|
Website:
http://www.sugen.com
Phone: +1 650 553-8300 |
Address:
230 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
Company Description
SUGEN, Inc. is a biopharmaceutical company that discovers and develops small molecule drugs used for diseases such as cancer and diabetes, as well as dermatologic, ophthalmic, neurological and immune disorders. The company uses crystallographic analysis and computational chemistry in its drug discovery process. The company's most advanced product, the SU101 is a platelet-derived growth factor receptor signalling pathway. In 1998, SUGEN International and SUGEN Europe were established as wholly-owned subsidiaries of the company.
Key People
| Chairman & Chief Executive Officer | STEPHEN EVANS-FREKE |
| Sr. VP & Chief Financial Officer | J. KNIGHTON |
| Treasurer | S.M. KANAYA |
| VP & Secretary | B.E. MACMILLIAN |
Related Business Topics
Breaking News
Reuters - September 04, 2009 5:52 AM
NEW HAVEN, Conn., Sept. 4 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a development-stage company focused on the discovery, development and commercialization of novel antibiotics for the treatment of acute care antibiotic-resistant infections, announced ...
Reuters - September 04, 2009 5:52 AM
NEW HAVEN, Conn., Sept. 4 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a development-stage company focused on the discovery, development and commercialization of novel antibiotics for the treatment of acute care antibiotic-resistant infections, announced ...
More Sugen, Inc. News
Ophthalmics
Breaking News, Expert Tips, Member Support, Treatment Options & More
www.everydayhealth.com
Breaking News, Expert Tips, Member Support, Treatment Options & More
www.everydayhealth.com
